[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "fullTimeEmployees": 146, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Taub MBA", "age": 76, "title": "Co-Founder & Chairman", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 138546, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Olivier  Taelman", "age": 51, "title": "CEO & Executive Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 876103, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Loic  Moreau", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 508760, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruno  Onkelinx", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mikaela  Kirkwood", "title": "Corporate Communication & Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. An  Moonen", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inge  Vanwittenbergh", "title": "Global Human Resource Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. DeMartino", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Remi  Renard", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeyakumar  Subbaroyan", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.17, "open": 9.2, "dayLow": 9.2, "dayHigh": 9.46, "regularMarketPreviousClose": 9.17, "regularMarketOpen": 9.2, "regularMarketDayLow": 9.2, "regularMarketDayHigh": 9.46, "beta": 0.551, "forwardPE": -5.47093, "volume": 36710, "regularMarketVolume": 36710, "averageVolume": 52168, "averageVolume10days": 90780, "averageDailyVolume10Day": 90780, "bid": 9.0, "ask": 9.57, "bidSize": 100, "askSize": 100, "marketCap": 320508352, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 20.0, "priceToSalesTrailing12Months": 62.50163, "fiftyDayAverage": 10.4994, "twoHundredDayAverage": 8.667185, "currency": "USD", "enterpriseValue": 238348592, "floatShares": 13901900, "sharesOutstanding": 34060400, "sharesShort": 59779, "sharesShortPriorMonth": 268182, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0021, "heldPercentInsiders": 0.42973, "heldPercentInstitutions": 0.20056, "shortRatio": 1.87, "shortPercentOfFloat": 0.0047, "bookValue": 3.04, "priceToBook": 3.0953946, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -43207000, "trailingEps": -1.62, "forwardEps": -1.72, "enterpriseToRevenue": 46.48, "enterpriseToEbitda": -5.267, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.41, "targetHighPrice": 27.14, "targetLowPrice": 15.08, "targetMeanPrice": 19.5, "targetMedianPrice": 18.1, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 44302000, "totalCashPerShare": 1.545, "ebitda": -45255000, "totalDebt": 12747000, "quickRatio": 3.6, "currentRatio": 3.941, "totalRevenue": 5128000, "debtToEquity": 14.619, "revenuePerShare": 0.179, "returnOnAssets": -0.21745001, "returnOnEquity": -0.40717998, "freeCashflow": -39521876, "operatingCashflow": -46389000, "revenueGrowth": 1.769, "grossMargins": 0.62246, "operatingMargins": -10.00246, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-06-03"}]